Annual revenue:
$2.84B+$419.80M(+17.35%)Summary
- As of today (September 13, 2025), BMRN annual revenue is $2.84 billion, with the most recent change of +$419.80 million (+17.35%) on December 31, 2024.
- During the last 3 years, BMRN annual revenue has risen by +$993.13 million (+53.80%).
- BMRN annual revenue is now at all-time high.
Performance
BMRN Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$827.47M+$94.87M(+12.95%)Summary
- As of today (September 13, 2025), BMRN quarterly revenue is $827.47 million, with the most recent change of +$94.87 million (+12.95%) on June 30, 2025.
- Over the past year, BMRN quarterly revenue has increased by +$118.81 million (+16.77%).
- BMRN quarterly revenue is now at all-time high.
Performance
BMRN Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$3.04B+$118.81M(+4.07%)Summary
- As of today (September 13, 2025), BMRN TTM revenue is $3.04 billion, with the most recent change of +$118.81 million (+4.07%) on June 30, 2025.
- Over the past year, BMRN TTM revenue has increased by +$450.19 million (+17.38%).
- BMRN TTM revenue is now at all-time high.
Performance
BMRN TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
BMRN Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +17.4% | +16.8% | +17.4% |
3 y3 years | +53.8% | +56.8% | +60.5% |
5 y5 years | +68.4% | +96.5% | +67.1% |
BMRN Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +53.8% | at high | +68.8% | at high | +60.5% |
5 y | 5-year | at high | +68.4% | at high | +102.6% | at high | +67.1% |
alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
BMRN Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $827.47M(+13.0%) | $3.04B(+4.1%) |
Mar 2025 | - | $732.60M(-0.8%) | $2.92B(+2.9%) |
Dec 2024 | $2.84B(+17.4%) | $738.22M(-0.6%) | $2.84B(+3.4%) |
Sep 2024 | - | $742.38M(+4.8%) | $2.75B(+6.0%) |
Jun 2024 | - | $708.66M(+9.0%) | $2.59B(+4.6%) |
Mar 2024 | - | $649.95M(+0.6%) | $2.48B(+2.4%) |
Dec 2023 | $2.42B(+18.2%) | $645.90M(+10.2%) | $2.42B(+5.7%) |
Sep 2023 | - | $585.97M(-1.5%) | $2.29B(+4.4%) |
Jun 2023 | - | $594.60M(+0.3%) | $2.19B(+3.1%) |
Mar 2023 | - | $592.95M(+15.0%) | $2.13B(+3.9%) |
Dec 2022 | $2.05B(+10.9%) | $515.78M(+5.2%) | $2.05B(+3.6%) |
Sep 2022 | - | $490.06M(-7.2%) | $1.98B(+4.3%) |
Jun 2022 | - | $527.87M(+2.7%) | $1.89B(+1.3%) |
Mar 2022 | - | $513.79M(+15.6%) | $1.87B(+1.4%) |
Dec 2021 | $1.85B(+0.2%) | $444.58M(+8.9%) | $1.85B(-0.4%) |
Sep 2021 | - | $408.34M(-19.0%) | $1.85B(-3.4%) |
Jun 2021 | - | $504.37M(+3.2%) | $1.92B(+4.5%) |
Mar 2021 | - | $488.79M(+8.3%) | $1.84B(-0.4%) |
Dec 2020 | $1.84B(+9.2%) | $451.30M(-4.8%) | $1.84B(+0.2%) |
Sep 2020 | - | $474.09M(+12.6%) | $1.84B(+1.1%) |
Jun 2020 | - | $421.21M(-15.0%) | $1.82B(+2.1%) |
Mar 2020 | - | $495.74M(+10.7%) | $1.78B(+5.7%) |
Dec 2019 | $1.69B(+12.6%) | $447.94M(-1.5%) | $1.69B(+6.0%) |
Sep 2019 | - | $454.90M(+18.6%) | $1.59B(+4.5%) |
Jun 2019 | - | $383.48M(-4.1%) | $1.52B(+0.4%) |
Mar 2019 | - | $400.05M(+13.5%) | $1.52B(+1.3%) |
Dec 2018 | $1.50B(+13.5%) | $352.54M(-8.8%) | $1.50B(-0.7%) |
Sep 2018 | - | $386.68M(+2.6%) | $1.51B(+3.3%) |
Jun 2018 | - | $376.91M(-1.1%) | $1.46B(+4.3%) |
Mar 2018 | - | $381.09M(+4.8%) | $1.40B(+6.1%) |
Dec 2017 | $1.32B(+18.8%) | $363.70M(+7.4%) | $1.32B(+5.1%) |
Sep 2017 | - | $338.79M(+7.1%) | $1.26B(+5.0%) |
Jun 2017 | - | $316.33M(+5.4%) | $1.20B(+1.3%) |
Mar 2017 | - | $300.20M(+0.0%) | $1.18B(+6.0%) |
Dec 2016 | $1.11B(+27.4%) | $300.09M(+7.8%) | $1.11B(+6.9%) |
Sep 2016 | - | $278.46M(-7.4%) | $1.04B(+7.7%) |
Jun 2016 | - | $300.72M(+28.8%) | $966.70M(+6.0%) |
Mar 2016 | - | $233.55M(+2.5%) | $911.99M(+4.0%) |
Dec 2015 | $872.18M(+16.3%) | $227.94M(+11.5%) | $876.97M(-0.3%) |
Sep 2015 | - | $204.49M(-16.9%) | $879.89M(+3.3%) |
Jun 2015 | - | $246.01M(+23.9%) | $851.68M(+6.7%) |
Mar 2015 | - | $198.53M(-14.0%) | $798.16M(+6.3%) |
Dec 2014 | $750.03M(+36.8%) | $230.85M(+31.0%) | $750.87M(+12.4%) |
Sep 2014 | - | $176.28M(-8.4%) | $667.78M(+6.3%) |
Jun 2014 | - | $192.50M(+27.3%) | $628.16M(+9.9%) |
Mar 2014 | - | $151.23M(+2.3%) | $571.75M(+4.3%) |
Dec 2013 | $548.45M(+10.8%) | $147.76M(+8.1%) | $547.95M(+3.2%) |
Sep 2013 | - | $136.67M(+0.4%) | $531.21M(+1.6%) |
Jun 2013 | - | $136.09M(+6.8%) | $522.65M(+2.6%) |
Mar 2013 | - | $127.43M(-2.7%) | $509.28M(+2.4%) |
Dec 2012 | $494.89M(+11.0%) | $131.02M(+2.3%) | $497.25M(+4.7%) |
Sep 2012 | - | $128.12M(+4.4%) | $474.86M(+2.8%) |
Jun 2012 | - | $122.71M(+6.3%) | $461.91M(+2.2%) |
Mar 2012 | - | $115.40M(+6.2%) | $451.82M(+1.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2011 | $446.00M(+20.0%) | $108.63M(-5.7%) | $445.55M(+1.6%) |
Sep 2011 | - | $115.17M(+2.3%) | $438.54M(+4.1%) |
Jun 2011 | - | $112.63M(+3.2%) | $421.12M(+5.2%) |
Mar 2011 | - | $109.13M(+7.4%) | $400.44M(+6.4%) |
Dec 2010 | $371.58M(+14.4%) | $101.61M(+4.0%) | $376.27M(+4.0%) |
Sep 2010 | - | $97.75M(+6.3%) | $361.73M(+4.7%) |
Jun 2010 | - | $91.95M(+8.2%) | $345.52M(+2.7%) |
Mar 2010 | - | $84.95M(-2.4%) | $336.36M(+3.4%) |
Dec 2009 | $324.72M(+9.5%) | $87.08M(+6.8%) | $325.39M(-3.6%) |
Sep 2009 | - | $81.54M(-1.5%) | $337.58M(+2.7%) |
Jun 2009 | - | $82.79M(+11.9%) | $328.69M(+6.0%) |
Mar 2009 | - | $73.98M(-25.5%) | $310.08M(+4.6%) |
Dec 2008 | $296.49M(+143.9%) | $99.28M(+36.7%) | $296.49M(+22.5%) |
Sep 2008 | - | $72.65M(+13.2%) | $242.07M(+24.5%) |
Jun 2008 | - | $64.17M(+6.3%) | $194.43M(+22.2%) |
Mar 2008 | - | $60.40M(+34.7%) | $159.14M(+30.9%) |
Dec 2007 | $121.58M(+44.4%) | $44.85M(+79.4%) | $121.58M(+23.1%) |
Sep 2007 | - | $25.01M(-13.4%) | $98.75M(+0.1%) |
Jun 2007 | - | $28.88M(+26.5%) | $98.67M(+5.8%) |
Mar 2007 | - | $22.84M(+3.7%) | $93.23M(+10.7%) |
Dec 2006 | $84.21M(+228.1%) | $22.02M(-11.7%) | $84.21M(+17.5%) |
Sep 2006 | - | $24.93M(+6.3%) | $71.66M(+31.9%) |
Jun 2006 | - | $23.45M(+69.8%) | $54.31M(+57.5%) |
Mar 2006 | - | $13.81M(+45.8%) | $34.49M(+34.4%) |
Dec 2005 | $25.67M(+37.7%) | $9.47M(+25.0%) | $25.67M(-14.7%) |
Sep 2005 | - | $7.58M(+109.0%) | $30.09M(+32.6%) |
Jun 2005 | - | $3.63M(-27.3%) | $22.69M(-4.0%) |
Mar 2005 | - | $4.99M(-64.1%) | $23.63M(+26.8%) |
Dec 2004 | $18.64M(>+9900.0%) | $13.90M(+7577.9%) | $18.64M(+292.9%) |
Sep 2004 | - | $181.00K(-96.0%) | $4.74M(+4.0%) |
Jun 2004 | - | $4.56M(>+9900.0%) | $4.56M(-62.3%) |
Mar 2004 | - | $0.00(0.0%) | $12.10M(-22.4%) |
Dec 2003 | $0.00(-100.0%) | $0.00(0.0%) | $15.60M(-16.7%) |
Sep 2003 | - | $0.00(-100.0%) | $18.73M(-16.0%) |
Jun 2003 | - | $12.10M(+246.1%) | $22.30M(+63.7%) |
Mar 2003 | - | $3.50M(+11.5%) | $13.62M(-2.1%) |
Dec 2002 | $13.92M(+19.0%) | $3.13M(-12.2%) | $13.92M(+1.7%) |
Sep 2002 | - | $3.57M(+4.3%) | $13.68M(-1.3%) |
Jun 2002 | - | $3.42M(-9.7%) | $13.86M(-1.7%) |
Mar 2002 | - | $3.79M(+30.9%) | $14.10M(+2.9%) |
Dec 2001 | $11.70M(-5.1%) | $2.90M(-22.6%) | $13.70M(-1.7%) |
Sep 2001 | - | $3.74M(+2.2%) | $13.95M(+7.2%) |
Jun 2001 | - | $3.66M(+7.8%) | $13.01M(+4.7%) |
Mar 2001 | - | $3.40M(+8.3%) | $12.43M(+0.8%) |
Dec 2000 | $12.33M(+76.7%) | $3.14M(+11.8%) | $12.33M(+7.2%) |
Sep 2000 | - | $2.81M(-9.0%) | $11.50M(+7.6%) |
Jun 2000 | - | $3.08M(-6.5%) | $10.70M(+22.0%) |
Mar 2000 | - | $3.30M(+42.5%) | $8.77M(+33.4%) |
Dec 1999 | $6.98M(+486.0%) | $2.31M(+15.8%) | $6.58M(+54.3%) |
Sep 1999 | - | $2.00M(+72.7%) | $4.26M(+88.4%) |
Jun 1999 | - | $1.16M(+4.8%) | $2.26M(+104.8%) |
Mar 1999 | - | $1.10M | $1.10M |
Dec 1998 | $1.19M(>+9900.0%) | - | - |
Dec 1997 | $0.00 | - | - |
FAQ
- What is BioMarin Pharmaceutical Inc. annual revenue?
- What is the all time high annual revenue for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. annual revenue year-on-year change?
- What is BioMarin Pharmaceutical Inc. quarterly revenue?
- What is the all time high quarterly revenue for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. quarterly revenue year-on-year change?
- What is BioMarin Pharmaceutical Inc. TTM revenue?
- What is the all time high TTM revenue for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. TTM revenue year-on-year change?
What is BioMarin Pharmaceutical Inc. annual revenue?
The current annual revenue of BMRN is $2.84B
What is the all time high annual revenue for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high annual revenue is $2.84B
What is BioMarin Pharmaceutical Inc. annual revenue year-on-year change?
Over the past year, BMRN annual revenue has changed by +$419.80M (+17.35%)
What is BioMarin Pharmaceutical Inc. quarterly revenue?
The current quarterly revenue of BMRN is $827.47M
What is the all time high quarterly revenue for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high quarterly revenue is $827.47M
What is BioMarin Pharmaceutical Inc. quarterly revenue year-on-year change?
Over the past year, BMRN quarterly revenue has changed by +$118.81M (+16.77%)
What is BioMarin Pharmaceutical Inc. TTM revenue?
The current TTM revenue of BMRN is $3.04B
What is the all time high TTM revenue for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high TTM revenue is $3.04B
What is BioMarin Pharmaceutical Inc. TTM revenue year-on-year change?
Over the past year, BMRN TTM revenue has changed by +$450.19M (+17.38%)